Li Dong-Run, Liu Bang-Quan, Li Ming-Hui, Qin Ying, Liu Jia-Cheng, Zheng Wen-Rui, Gong Ting-Ting, Gao Shan-Yan, Wu Qi-Jun
Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
Nutr J. 2025 May 17;24(1):81. doi: 10.1186/s12937-025-01151-3.
BACKGROUND: The dietary index for gut microbiota (DI-GM) is a newly proposed index that evaluates dietary intake patterns associated with gut microbial health. Limited studies have examined whether DI-GM influences gastrointestinal (GI) cancer risk. We aimed to investigate the association between DI-GM and GI cancer risk and evaluate its combined effect with genetic risk. METHODS: We included 178,148 UK Biobank participants who completed at least one 24-hour dietary recall. DI-GM was constructed from 13 dietary components known to influence gut microbial health and was divided into three groups. The GI cancer polygenic risk score was calculated from 205 significant single-nucleotide polymorphisms related to esophageal cancer (EC), gastric cancer (GC), and colorectal cancer (CRC). Cox proportional hazards models with hazard ratios (HRs) and 95% confidence intervals (CIs) were used to estimate the associations between DI-GM, genetic risk, and GI cancer. RESULTS: During a median follow-up of 13.47 years, 2,682 participants developed GI cancer. In fully adjusted models, higher DI-GM was associated with a lower GI cancer risk (HR for GI cancer: 0.83; 95% CI: 0.75-0.92; HR for EC: 0.62, 95% CI: 0.45-0.86; HR for GC: 0.99, 95% CI: 0.71-1.39; HR for CRC: 0.84, 95% CI: 0.75-0.95), compared with participants in the lowest DI-GM category. In joint analysis, individuals with higher DI-GM and lower genetic risk had lower GI cancer risk, with HRs (95% CI) of 0.28 (0.21, 0.36), 0.50 (0.42, 0.58) for low and intermediate genetic risk, respectively, compared with those with low DI-GM and high genetic risk. And a significant interaction between DI-GM and genetic risk was observed. CONCLUSION: Higher DI-GM was associated with a lower risk of GI cancer including EC and CRC. These findings highlight the importance of considering a gut microbiota-friendly diet and genetic risk in GI cancer prevention.
背景:肠道微生物群饮食指数(DI-GM)是一项新提出的指数,用于评估与肠道微生物健康相关的饮食摄入模式。仅有有限的研究探讨了DI-GM是否会影响胃肠道(GI)癌症风险。我们旨在研究DI-GM与GI癌症风险之间的关联,并评估其与遗传风险的联合作用。 方法:我们纳入了178,148名完成至少一次24小时饮食回忆的英国生物银行参与者。DI-GM由13种已知会影响肠道微生物健康的饮食成分构建而成,并分为三组。胃肠道癌症多基因风险评分由与食管癌(EC)、胃癌(GC)和结直肠癌(CRC)相关的205个显著单核苷酸多态性计算得出。使用带有风险比(HRs)和95%置信区间(CIs)的Cox比例风险模型来估计DI-GM、遗传风险和GI癌症之间的关联。 结果:在中位随访13.47年期间,2682名参与者患上了GI癌症。在完全调整模型中,与DI-GM类别最低的参与者相比,较高的DI-GM与较低的GI癌症风险相关(GI癌症的HR:0.83;95%CI:0.75 - 0.92;EC的HR:0.62,95%CI:0.45 - 0.86;GC的HR:0.99,95%CI:0.71 - 1.39;CRC的HR:0.84,95%CI:0.75 - 0.95)。在联合分析中,与DI-GM低且遗传风险高的个体相比,DI-GM高且遗传风险低的个体患GI癌症的风险较低,低遗传风险和中等遗传风险的HR(95%CI)分别为0.28(0.21,0.36)、0.50(0.42,0.58)。并且观察到DI-GM与遗传风险之间存在显著交互作用。 结论:较高的DI-GM与包括EC和CRC在内的GI癌症风险较低相关。这些发现凸显了在GI癌症预防中考虑有利于肠道微生物群的饮食和遗传风险的重要性。
BMC Cardiovasc Disord. 2025-4-28
Eur Arch Psychiatry Clin Neurosci. 2024-12-23
Cancer Epidemiol Biomarkers Prev. 2025-2-6
MedComm (2020). 2024-11-20
Eur Arch Psychiatry Clin Neurosci. 2024-10-8